ZA869494B - Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas - Google Patents

Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas

Info

Publication number
ZA869494B
ZA869494B ZA869494A ZA869494A ZA869494B ZA 869494 B ZA869494 B ZA 869494B ZA 869494 A ZA869494 A ZA 869494A ZA 869494 A ZA869494 A ZA 869494A ZA 869494 B ZA869494 B ZA 869494B
Authority
ZA
South Africa
Prior art keywords
human
antigen
certain
monoclonal antibodies
small cell
Prior art date
Application number
ZA869494A
Other languages
English (en)
Inventor
Karl Erik Hellstrom
Joseph P Brown
Ingegerd Hellstrom
Hans Marquard
Original Assignee
Bristol Myers Co
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co, Oncogen filed Critical Bristol Myers Co
Publication of ZA869494B publication Critical patent/ZA869494B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA869494A 1986-02-26 1986-12-18 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas ZA869494B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/834,172 US5185432A (en) 1986-02-26 1986-02-26 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas

Publications (1)

Publication Number Publication Date
ZA869494B true ZA869494B (en) 1987-10-28

Family

ID=25266276

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA869494A ZA869494B (en) 1986-02-26 1986-12-18 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas

Country Status (28)

Country Link
US (1) US5185432A (xx)
JP (1) JPS62220197A (xx)
KR (2) KR900006338B1 (xx)
CN (1) CN87100927A (xx)
AT (1) AT400577B (xx)
AU (1) AU612967B2 (xx)
BE (1) BE1000611A5 (xx)
CA (1) CA1312025C (xx)
CH (1) CH675880A5 (xx)
DD (2) DD276165A5 (xx)
DE (1) DE3705276A1 (xx)
DK (1) DK98187A (xx)
ES (1) ES2004245A6 (xx)
FI (1) FI870764A (xx)
FR (1) FR2596062B1 (xx)
GB (1) GB2186885B (xx)
GR (1) GR870294B (xx)
IE (1) IE60286B1 (xx)
IT (1) IT1203511B (xx)
LU (1) LU86786A1 (xx)
NL (1) NL8700415A (xx)
NO (1) NO174719C (xx)
NZ (1) NZ219338A (xx)
OA (1) OA08485A (xx)
PT (1) PT84370B (xx)
SE (2) SE467988B (xx)
YU (1) YU46189B (xx)
ZA (1) ZA869494B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung
JPH0813840B2 (ja) * 1987-03-31 1996-02-14 協和醗酵工業株式会社 抗ヒト肺腺癌単クロ−ン性抗体
US5134075A (en) * 1989-02-17 1992-07-28 Oncogen Limited Partnership Monoclonal antibody to novel antigen associated with human tumors
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0863402B1 (en) 1997-03-03 2005-09-14 Amersham Biosciences UK Limited In-situ cell extraction and assay method
DE19725133A1 (de) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Nachweis von seltenen Zellen
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
US6117981A (en) * 1999-06-03 2000-09-12 Cytoclonal Pharmaceutics, Inc. Hybridomas for lung cancer marker and monoclonal antibodies thereof
CA2389916A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. B7-like polynucleotides, polypeptides, and antibodies
ATE385504T1 (de) 2000-06-06 2008-02-15 Bristol Myers Squibb Co Nukleinsäuren und polypeptide, die sich auf b7 beziehen und ihre verwendungen zur immunmodulierung
TWI317285B (en) * 2000-07-28 2009-11-21 Dainippon Sumitomo Pharma Co New use and kit for remedies for cancer
CN101724072B (zh) * 2008-10-27 2013-10-09 谷为岳 一种抗肿瘤的单克隆抗体的序列及应用
GB0916686D0 (en) * 2009-09-23 2009-11-04 Univ Manchester Metropolitan Treatment of cancer
US8802091B2 (en) 2010-03-04 2014-08-12 Macrogenics, Inc. Antibodies reactive with B7-H3 and uses thereof
US9150656B2 (en) 2010-03-04 2015-10-06 Macrogenics, Inc. Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
US9696320B2 (en) * 2010-09-17 2017-07-04 National Institute Of Advanced Industrial Science And Technology Lung cancer differential marker
CN102391992B (zh) * 2011-11-03 2012-08-29 潘世扬 抗人非小细胞肺癌单克隆抗体及其应用
KR102514317B1 (ko) 2016-04-15 2023-03-27 마크로제닉스, 인크. 신규 b7-h3-결합 분자, 그것의 항체 약물 콘쥬게이트 및 그것의 사용 방법
CN111662371B (zh) * 2020-04-30 2023-07-04 美康生物科技股份有限公司 细胞角蛋白19片段抗原及其制备方法和应用
CN112300284B (zh) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 核酸筛选结合抗体检测用于癌症检测中的用途及其制备的试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies

Also Published As

Publication number Publication date
GB2186885B (en) 1990-10-03
KR880010438A (ko) 1988-10-08
CN87100927A (zh) 1988-10-05
AU612967B2 (en) 1991-07-25
NZ219338A (en) 1991-11-26
NO174719C (no) 1994-06-22
FI870764A0 (fi) 1987-02-23
YU25787A (en) 1990-12-31
BE1000611A5 (fr) 1989-02-21
SE8700805D0 (sv) 1987-02-25
NO174719B (no) 1994-03-14
KR900006338B1 (ko) 1990-08-28
IT1203511B (it) 1989-02-15
PT84370B (pt) 1989-11-10
DD276165A5 (de) 1990-02-14
DD266028A5 (de) 1989-03-22
OA08485A (fr) 1988-07-29
IT8719491A0 (it) 1987-02-25
GB8703700D0 (en) 1987-03-25
GR870294B (en) 1987-06-30
GB2186885A (en) 1987-08-26
KR870008026A (ko) 1987-09-23
NL8700415A (nl) 1987-09-16
LU86786A1 (fr) 1987-09-15
SE9201529A0 (sv) 1992-05-14
ATA43587A (de) 1995-06-15
DK98187D0 (da) 1987-02-25
FR2596062A1 (fr) 1987-09-25
IE60286B1 (en) 1994-06-29
PT84370A (en) 1987-03-01
CA1312025C (en) 1992-12-29
NO870770D0 (no) 1987-02-25
FR2596062B1 (fr) 1990-06-08
YU46189B (sh) 1993-05-28
DK98187A (da) 1987-08-27
ES2004245A6 (es) 1988-12-16
US5185432A (en) 1993-02-09
DE3705276A1 (de) 1987-08-27
SE8700805L (sv) 1987-10-22
SE9201529D0 (sv) 1992-05-14
FI870764A (fi) 1987-08-27
NO870770L (no) 1987-08-27
AT400577B (de) 1996-01-25
AU6927287A (en) 1987-08-27
IE870487L (en) 1987-08-26
SE467988B (sv) 1992-10-12
CH675880A5 (xx) 1990-11-15
JPS62220197A (ja) 1987-09-28

Similar Documents

Publication Publication Date Title
ZA859761B (en) Monoclonal antibodies and antigen for human non-small cell lung carcinomas
ZA869494B (en) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas
IL76142A0 (en) Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
ZA858371B (en) Monoclonal antibodies for human non-small cell lung carcinomas
AU2460988A (en) Simultaneous immunoassay for the determination of antigens and antibodies
EP0240344A3 (en) Monoclonal antibodies and their use
GB8304538D0 (en) Antibodies and antigens
PT79076A (en) Antigens and monoclonal antibodies reactive against merozites of eimeria spp.
EP0160446A3 (en) Breast tumor-associated antigen and monoclonal antibodies specific thereto
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
GB8624899D0 (en) Monoclonal antibodies
IL82930A (en) Antibodies for the detection of mammalian carcinomas and their preparation
IL61641A0 (en) Immunological detection of human cancer cells and antigens and antibodies for use therein
GB8621910D0 (en) Monoclonal antibodies
EP0203967A4 (en) SPECIFIC ONCO-FETAL MONOCLONAL ANTIBODIES, METHODS OF PREPARATION AND USE.
GB8715347D0 (en) Monoclonal antibodies
EP0253646A3 (en) Anti-human gastric cancer monoclonal antibody
GB8616174D0 (en) Monoclonal antibodies
IL83342A0 (en) Monoclonal antibodies,their preparation and their use
EP0307476A4 (en) Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
GB8506373D0 (en) Antigens antibodies
PT81454B (en) Monoclonal antibodies specific for human squamous lung carcinoma cells their preparation and use
AU5726986A (en) Monoclonal antibodies for human non-small cell lung carcinomas
AU546797B2 (en) Monoclonal antibodies against tumor antigens and method